- The Translational Research Institute (TRI) in Brisbane, Australia, is a premier, award-winning medical research facility located on the Princess Alexandra Hospital campus. Opened in 2012, this $356 million, purpose-built, glass-fronted venue fosters collaboration between over 1,000 researchers, clinicians, and industry partners, offering advanced PC2/PC3 labs, a biopharmaceutical manufacturing facility, and specialized meeting spaces.
Key Features and Venue Capabilities
- Location: Co-located with the Princess Alexandra Hospital in Brisbane, providing direct access to patients and clinical trials.
- Infrastructure: The facility features four floors of laboratories, a vivarium, a Cell Therapies clean room facility, and a large lecture theater.
- Design: The building is designed to encourage collaboration and transparency, with extensive use of glass and flexible, interconnected spaces.
- Capacity: It supports a “community of research” with, including 1000+ researchers and eight early-stage companies.
- Technology & Sustainability: Includes a Tier 2.5 data centre, 3.2MW of standby generation, and 70kW of photovoltaic panels.
- Atmosphere: The environment is enhanced by curated, rotating art installations, including pieces from the Turrbal and Yuggera people.
The TRI is a partnership between The University of Queensland, Queensland University of Technology, Mater Research, and Queensland Health.
